Results 221 to 230 of about 88,341 (288)

Comparative Antifungal Activity of Medicinal Plant Extracts and Essential Oils Against Clinical Isolates of <i>Candida albicans</i> from Denture Stomatitis Patients. [PDF]

Plants (Basel)
Fathi N, Hong JH, Lotfipour F, Ghaffari S, Abbasi R, Asgharian P, Attaran R, Hamishehkar H, Kouhsoltani M, Kim KH.   +9 more
europepmc   +1 more source

Interdisciplinary Study of the Clinical Phenotype of Patients with Fibrodysplasia Ossificans Progressiva (FOP) in Dental Practice: A Cross-Sectional Clinical-Statistical Analysis. [PDF]

J Clin Med
Danshina S, Sevbitov A, Kazumova A, Borisov V, Timoshin A, Kuznetsova M, Dorofeev A.   +6 more
europepmc   +1 more source

Effects of glycyrrhizin on healing and prevention of recurrent aphthous stomatitis in hamster models. [PDF]

PLoS One
Shiba F, Maekawara S, Furusho H, Ishida E, Shigeishi H, Ohta K, Miyauchi M.   +6 more
europepmc   +1 more source

Photobiomodulation in the management of oral lesions: a targeted, evidence-based approach. [PDF]

Braz Oral Res
Koth VS, Gabriel AF, Deckmann I, Castilho RM, Nor F, Lamers ML, Figueiredo JAP, Martins MD.   +7 more
europepmc   +1 more source

Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms are Not Associated With Recurrent Aphthous Stomatitis: A Case-Control Study. [PDF]

Int Dent J
Magrì C, Vezzosi A, Vinella A, Mariggiò MA, De Falco D, Petruzzi M.   +5 more
europepmc   +1 more source

Oral aphthosis in children: baseline clinical features associated with diagnostic categories in a single-centre retrospective cohort. [PDF]

Eur J Pediatr
Dipasquale RF, Sinopoli P, Adessi S, Pascuzzo A, Gallizzi R.   +4 more
europepmc   +1 more source

Unravelling the genomic epidemiology and antigenic evolution of Chandipura virus: A genetically constrained neurotropic threat. [PDF]

PLoS Negl Trop Dis
Kuri PR, Sharma A.
europepmc   +1 more source

Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd) in Patients with Hormone Receptor (HR) Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer. [PDF]

J Clin Pharmacol
Tang Z, Lim K, Jiang Y, Denduluri N, Rokutanda N, Pan Y, Hong Y, Ren S, Vajjah P, Zhou D.   +9 more
europepmc   +1 more source

Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive HER2-negative breast cancer: safety and patient-reported outcomes from the phase III TROPION-Breast01 study. [PDF]

ESMO Open
Rugo HS, Jhaveri K, Pernas S, Pistilli B, Im SA, De Laurentiis M, Wang S, Martínez Jañez N, Borges G, Cescon DW, Hattori M, Lu YS, Hamilton E, Zhang Q, Tsurutani J, Kalinsky K, Rubini Liedke PE, Nowecki Z, Tolaney SM, Zhao K, Atuah K, Verma D, Xu B, Bardia A, TROPION-Breast01 investigators.   +24 more
europepmc   +1 more source